All data are based on the daily closing price as of June 27, 2025
l

L&C Bio

290650.KQ
20.50 USD
0.74
+3.74%

Overview

Last close
20.50 usd
Market cap
465.10M usd
52 week high
23.67 usd
52 week low
10.84 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
8.6169
Price/Book Value
2.23
Enterprise Value
540.37M usd
EV/Revenue
10.0553
EV/EBITDA
5.0581

Key financials

Revenue TTM
53.74M usd
Gross Profit TTM
27.32M usd
EBITDA TTM
5.34M usd
Earnings per Share
3.11 usd
Dividend
0.04 usd
Total assets
293.17M usd
Net debt
N/A usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top